University of California, Los Angeles
BioResearch Product Faire™
0 Comments Click here to read/write comments
Tags: University of California Los Angeles, Los Angeles, UCLA, 2020
With 290 medical research centers and distinctive institutes, the University of California, Los Angeles is a powerhouse research university employing some of the leading life science researchers in the world. With a powerful global reputation, the University of California, Los Angeles offers a promising marketplace for lab suppliers working to market their biotech solutions and increase lab sales.
UCLA: Meet Nearly 500 Top Researchers this Fall
Perhaps you are a lab supplier with a long history of doing business with UCLA life science researchers, or maybe you are brand new to the market. Regardless of your time investment, increasing lab sales at the University of California, Los Angeles is as easy as taking advantage of Biotechnology Calendar, Inc.’s well-established connections at the university and exhibiting at the upcoming UCLA event. Why should you focus on this marketplace? Consider these most recent funding statistics for the University of California, Los Angeles:
0 Comments Click here to read/write comments
Tags: CA, University of California Los Angeles, California, funding resource, Los Angeles, LAVS
According to the World Health Organization, more than 36.7 million people around the world are infected with Human Immunodeficiency Virus (HIV). Although there is not yet a cure for HIV, some treatments are able to slow the spread of the virus. Researchers around the world study the virus with the hope of one day creating a cure to attack the virus. A team of researchers from the University of Southern California in Los Angeles are taking a different approach to fighting HIV - by creating a treatment that boosts the immune system instead of attacking the virus.
0 Comments Click here to read/write comments
Tags: CA, University of Southern California, USC, Los Angeles, BioResearch Product Faire Event, HIV research, 2018, HIV treatment
Researchers from UCLA and partnering schools guided by Laurent Bentolila found evidence supporting the spread of malignant cells through angiotropism with vascular co-option, and even suggested they may be related or identical processes. These findings were published in Nature Scientific Reports. With angiotropism being the ability for cells to travel along surface of blood vessels, but not be inside of them, also called extravascular migratory metastasis (EVMM) and vascular co-option being the ability for a tumor to use a blood supply and travel along it, this means cancer has an outlet to spread outside of the bloodstream. The spread outside of the bloodstream means some current methods of treating cancer would be ineffective.
“... if the metastasizing cells are on the outside of the blood vessels, they escape exposure to the treatment and continue to spread cancer.”
-Laurent A. Bentolila
Read More
0 Comments Click here to read/write comments
Tags: CA, University of California Los Angeles, cancer research, Los Angeles, Cancer, LAVS, UCLA, laboratory, lab products, 2016
A team of biochemists at UCLA have created a novel system of converting glucose into highly useful chemical compounds, such as those needed to create biofuels and pharmaceuticals. Previous research endeavors relied on using cells to convert sugar into desired compounds. This has been difficult to achieve because cells would rather use sugar for their own natural uses, such as building proteins and cell walls. The UCLA biochemists have recently developed a way to achieve the conversion of glucose into desired compounds- without using cells.
Read More
0 Comments Click here to read/write comments
Tags: CA, University of California Los Angeles, Los Angeles, Biochemistry, chemistry research, Chemistry, LAVS, UCLA, Biotechnology Vendor Showcase, 2016, Western, glucose
A UCLA cancer research team has recently received a $7.6 million grant from the California Institute for Regenerative Medicine. This award will support research into genetically engineered white blood cells which can selectively target and kill tumor cells, while simultaneously activating other immune cells to do the same.
Read More
0 Comments Click here to read/write comments
Tags: CA, University of California Los Angeles, Stem Cells, Los Angeles, genetic engineering, UCLA, Biotechnology Vendor Showcase, new funding, cancer research funding, tumor cells
The University of Southern California is known around the world as being a leader in many fields, including life science research, and even has a separate campus dedicated to teaching and researching health sciences. With 6 basic science departments, 18 clinical departments, 7 research institutes, and dozens of research centers and programs, the Keck School of Medicine on the USC Health Science Campus is continuing to expand and increase life science capabilities. In 2015, the university opened a new $15 million Center for Pullmonary Research as well as a new $10 million Center for Convergent Bioscience.
The ever-growing campus is adding a new department to its impressive list, with the recent establishment of a Translational Genomics Department to be located in the Harlyne J. Norris Research Tower on the USC Health Sciences campus.
Read More
0 Comments Click here to read/write comments
Tags: CA, University of Southern California, Southwest, USC, Los Angeles, BRPF, 2016, BioResearch Product Faire, Translational Genomics
When vital organs in the body, such as the lungs, begin to fail, an organ transplant can be a solution to the problem. However, receiving a transplant may have its own complications, such as the body rejecting its new organ.
Now, thanks to a generous donation of $1 million dollars from Michael and Linda Keston, researchers from the Division of Pulmonary and Critical Care Medicine at the UCLA David Geffen School of Medicine will be able to continue studying lung disease and the organ rejection commonly following a transplant.
Read More
0 Comments Click here to read/write comments
Tags: CA, University of California Los Angeles, Los Angeles, LAVS, UCLA, Biotechnology Vendor Showcase, new funding, 2016, Lung Disease, organ transplant, organ rejection
During pregnancy, much of a fetus’ development is contingent on the condition and function of the placenta. It is responsible for the transmission of substances from mother to child that are critical to early development, including blood, oxygen and nutrients, without which the fetus could not exist. Sometimes, however, environmental effects can cause deficiencies in the placenta, which can lead to harmful side effects such as preterm birth or even death.
0 Comments Click here to read/write comments
Tags: CA, University of California Los Angeles, Medical Research, California, Los Angeles, Development, UCLA, Biotechnology Vendor Showcase, NIH funding, NIH award, Southwest Region, 2016, best science tradeshows, pollution, pregnancy
Like any living organism, cancer cells rely on fuel in order to survive and grow. Unfortunately for many, the growth of cancer cells is extremely deleterious to human health. That is why a major facet of cancer research currently involves locating and preventing the mechanism for fueling cancer cells.
1 Comment Click here to read/write comments
Tags: CA, University of California Los Angeles, cancer research, California, Los Angeles, Cancer Treatment, 2015, LAVS, UCLA, Research Funding, Life Science, Biotechnology Vendor Showcase, Southwest Region, Prostate cancer